MedPath

Ammonia N 13

These highlights do not include all the information needed to use AMMONIA N 13 INJECTION for intravenous use safely and effectively. See full prescribing information for AMMONIA N 13 INJECTION. Ammonia N 13 Injection for intravenous use Initial U.S. Approval: 2007

Approved
Approval ID

bbc03271-8d23-4e89-aa32-cff581cdc275

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 5, 2023

Manufacturers
FDA

University of Alabama at Birmingham

DUNS: 063690705

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

NH3N13

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code69714-001
Application NumberANDA211698
Product Classification
M
Marketing Category
C73584
G
Generic Name
NH3N13
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateJune 12, 2019
FDA Product Classification

INGREDIENTS (2)

AMMONIA N-13Active
Quantity: 37.5 mCi in 1 mL
Code: 9OQO0E343Z
Classification: ACTIB
SODIUM CHLORIDEInactive
Quantity: 9 mg in 1 mL
Code: 451W47IQ8X
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.